Caseware UK (AP4) 2016.0.181 2016.0.181 2017-09-302017-09-30The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.truefalseHolding cofalse2016-10-01 02543120 2016-10-01 2017-09-30 02543120 2017-09-30 02543120 2016-09-30 02543120 c:Director1 2016-10-01 2017-09-30 02543120 c:Director2 2016-10-01 2017-09-30 02543120 d:CurrentFinancialInstruments 2017-09-30 02543120 d:CurrentFinancialInstruments 2016-09-30 02543120 d:Non-currentFinancialInstruments 2017-09-30 02543120 d:Non-currentFinancialInstruments 2016-09-30 02543120 d:CurrentFinancialInstruments d:WithinOneYear 2017-09-30 02543120 d:CurrentFinancialInstruments d:WithinOneYear 2016-09-30 02543120 d:ShareCapital 2017-09-30 02543120 d:ShareCapital 2016-09-30 02543120 d:SharePremium 2017-09-30 02543120 d:SharePremium 2016-09-30 02543120 d:RetainedEarningsAccumulatedLosses 2017-09-30 02543120 d:RetainedEarningsAccumulatedLosses 2016-09-30 02543120 c:OrdinaryShareClass1 2016-10-01 2017-09-30 02543120 c:OrdinaryShareClass1 2017-09-30 02543120 c:FRS102 2016-10-01 2017-09-30 02543120 c:AuditExempt-NoAccountantsReport 2016-10-01 2017-09-30 02543120 c:FullAccounts 2016-10-01 2017-09-30 02543120 c:PrivateLimitedCompanyLtd 2016-10-01 2017-09-30 xbrli:shares iso4217:GBP xbrli:pure

Registered number: 02543120









NIMROD LIFE SCIENCES LIMITED







UNAUDITED

FINANCIAL STATEMENTS

INFORMATION FOR FILING WITH THE REGISTRAR

FOR THE YEAR ENDED 30 SEPTEMBER 2017

 
NIMROD LIFE SCIENCES LIMITED
REGISTERED NUMBER: 02543120

BALANCE SHEET
AS AT 30 SEPTEMBER 2017

2017
2016
Note
£
£

FIXED ASSETS
  

Investments
 4 
243,418
243,418

CURRENT ASSETS
  

Debtors: amounts falling due within one year
 5 
-
67

Cash at bank and in hand
  
947,245
556,312

  
947,245
556,379

Creditors: amounts falling due within one year
 6 
(3,284)
(11,200)

NET CURRENT ASSETS
  
 
 
943,961
 
 
545,179

  

NET ASSETS
  
1,187,379
788,597


CAPITAL AND RESERVES
  

Called up share capital 
 7 
8
8

Share premium account
  
109,409
109,409

Profit and loss account
  
1,077,962
679,180

  
1,187,379
788,597


The directors consider that the Company is entitled to exemption from audit under section 477 of the Companies Act 2006 and members have not required the Company to obtain an audit for the year in question in accordance with section 476 of Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and in accordance with the provisions of FRS 102 Section 1A - small entities.

The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The Company has opted not to file the profit and loss account in accordance with provisions applicable to companies subject to the small companies' regime.

The financial statements were approved and authorised for issue by the board and were signed on its behalf by: 



Mr S J Lawrence
Mr M J M Rawe
Director
Director


Date: 20 March 2018
The notes on pages 2 to 4 form part of these financial statements.

Page 1

 
NIMROD LIFE SCIENCES LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 SEPTEMBER 2017

1.


GENERAL INFORMATION

Nimrod Life Sciences Limited limited by shares and incorporated in England. Its registered office is Unit 1, Priors Hall, Widdington, Saffron Walden, Essex, CB11 3SB.

2.ACCOUNTING POLICIES

 
2.1

BASIS OF PREPARATION OF FINANCIAL STATEMENTS

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with Section 1A of Financial Reporting Standard 102, the Financial Reporting Standard applicable in the UK and the Republic of Ireland and the Companies Act 2006.

The following principal accounting policies have been applied:

 
2.2

VALUATION OF INVESTMENTS

Investments in subsidiaries are measured at cost less accumulated impairment.

 
2.3

DEBTORS

Short term debtors are measured at transaction price, less any impairment. Loans receivable are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method, less any impairment.

 
2.4

CREDITORS

Short term creditors are measured at the transaction price. Other financial liabilities, including bank loans, are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method.

 
2.5

INTEREST INCOME

Interest income is recognised in the Profit and Loss Account using the effective interest method.

 
2.6

TAXATION

Tax is recognised in the Profit and Loss Account, except that a charge attributable to an item of income and expense recognised as other comprehensive income or to an item recognised directly in equity is also recognised in other comprehensive income or directly in equity respectively.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the balance sheet date in the countries where the Company operates and generates income.


3.


EMPLOYEES

The Company has no employees other than the directors, who did not receive any remuneration (2016 - £NIL).

Page 2

 
NIMROD LIFE SCIENCES LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 SEPTEMBER 2017

4.


FIXED ASSET INVESTMENTS





Investments in subsidiary companies

£



COST OR VALUATION


At 1 October 2016
243,418



At 30 September 2017

243,418






NET BOOK VALUE



At 30 September 2017
243,418



At 30 September 2016
243,418


5.


DEBTORS

2017
2016
£
£


Amounts owed by group undertakings
-
67



6.


CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

2017
2016
£
£

Amounts owed to group undertakings
1,078
-

Other creditors
700
9,700

Accruals and deferred income
1,506
1,500

3,284
11,200


Page 3

 
NIMROD LIFE SCIENCES LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 SEPTEMBER 2017

7.


SHARE CAPITAL

2017
2016
£
£
Allotted, called up and fully paid 



8 Ordinary shares of £1 each
8
8

 
Page 4